Holen Sie sich die Stockscreener-App
4.22
14.67%
-0.79
Schlusskurs vom Vortag:
$5.01
Offen:
$4.24
24-Stunden-Volumen:
4.30M
Relative Volume:
1.83
Marktkapitalisierung:
$10.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-3.6696
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
+216.67%
1M Leistung:
+117.01%
6M Leistung:
-0.81%
1J Leistung:
-53.34%
1-Tages-Spanne:
$3.8322
$4.34
1-Wochen-Bereich:
$1.37
$6.2999
52-Wochen-Spanne:
$1.3259
$21.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
4.22 | 12.76M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.99 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
701.04 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
315.13 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.61 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch - Investing.com
Earnings Scheduled For March 13, 2026 - Benzinga
ACXP: Cash up, losses down, and ibezapolstat advances toward pivotal Phase 3 trials - TradingView
Acurx starts recurrent C. diff trial to treat and prevent - Stock Titan
Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Sahm
Pullback Watch: What are the risks of holding Acurx Pharmaceuticals Inc2026 Movers & Weekly Top Gainers Trade List - baoquankhu1.vn
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Times Record News
Acurx Pharmaceuticals 10-K: $0 Revenue, Net Loss $7.97M - TradingView
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Why is Acurx Pharmaceuticals stock falling Thursday? - MSN
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Best Pharmaceutical Stocks To Follow NowMarch 11th - MarketBeat
Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Acurx Launches New Trial Amidst Promising Developments in C. Difficile Treatment - StocksToTrade
Acurx Pharma shares rise by 29% on new trial for breakthrough antibiotic ‘ibezapolstat’ - Mugglehead Investment Magazine
Acurx Launches Revolutionary Trials for C. difficile Drug - timothysykes.com
Acurx Pharmaceuticals Inc expected to post a loss of $1.01 a shareEarnings Preview - TradingView
Will Acurx Pharma's Ibezapolstat Redefine Treatment For C. Diff Infection? - RTTNews
Acurx Pharma shares rise by 29% after launching trial for breakthrough antibiotic 'ibezapolstat' - Mugglehead Investment Magazine
ACXP Acurx Pharmaceuticals NASDAQ 10 Mar 2026: Ibezapolstat trial headlines earnings - Meyka
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Acurx Pharmaceuticals Expands Ibezapolstat Trials in Europe - StocksToTrade
Acurx Pharmaceuticals (ACXP.US) will release its earnings report before the market opens on March 13. - 富途牛牛
Acurx Launches New Ibezapolstat Clinical Trials for Recurrent C. difficile Infection (rCDI) with Potential to Transform CDI Treatment and Prevention - Minichart
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Acurx Advances Ibezapolstat Program for Recurrent C. difficile - TipRanks
Acurx tests one-drug approach in 20-patient C. diff relapse trial - Stock Titan
Acurx Pharmaceuticals (ACXP) secures new US patent for DNA polymerase IIIC inhibitors - MSN
Aug Closing: What are the risks of holding Acurx Pharmaceuticals Inc2025 Dividend Review & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
How Acurx Pharmaceuticals Inc. stock performs in weak economy2025 Fundamental Recap & Risk Controlled Daily Plans - Naître et grandir
Acurx Pharmaceuticals (ACXP) Expected to Announce Earnings on Friday - Defense World
ACXP SEC FilingsAcurx Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ACXP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ACXP Should I Buy - Intellectia AI
Aug PostEarnings: What is the dividend yield of Acurx Pharmaceuticals Inc2025 Biggest Moves & Safe Entry Zone Identification - baoquankhu1.vn
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Finviz
Is Acurx Pharmaceuticals Inc. stock trading at a premium valuation2025 Support & Resistance & Precise Swing Trade Alerts - mfd.ru
Can Acurx Pharmaceuticals Inc. keep up with sector leaders2025 Fundamental Recap & AI Enhanced Trading Signals - mfd.ru
What is Acurx Pharmaceuticals Inc. s 5 year growth outlookQuarterly Profit Report & AI Driven Stock Price Forecasts - mfd.ru
ACXP PE Ratio & Valuation, Is ACXP Overvalued - Intellectia AI
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update - Yahoo Finance
Acurx Pharmaceuticals Approaches Critical Phase 3 Trial Launch - AD HOC NEWS
What Wall Street predicts for Acurx Pharmaceuticals Inc. stock priceWeekly Stock Analysis & Safe Entry Momentum Stock Tips - mfd.ru
Acurx patent backs new antibiotics for C. diff and MRSA - Stock Titan
Can Acurx Pharmaceuticals Inc. weather a recessionCPI Data & Low Risk High Win Rate Picks - mfd.ru
Jobs Data: What are the risks of holding Acurx Pharmaceuticals Inc2025 Volume Leaders & AI Powered Market Trend Analysis - baoquankhu1.vn
Street Watch: Is Acurx Pharmaceuticals Inc stock undervalued right now2025 Price Momentum & Daily Oversold Bounce Ideas - baoquankhu1.vn
Loss-Making Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Expected To Breakeven In The Medium-Term - Yahoo Finance
Will Acurx Pharmaceuticals Inc. stock remain a Wall Street favoriteVolatility Trading Techniques & Small Budget Trading Ideas - Bollywood Helpline
Why Acurx Pharmaceuticals Inc. stock is in analyst buy zoneMarket Sentiment Indicators & Double Digit Profit Strategies - bollywoodhelpline.com
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):